 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Europe Faces Crunch Decision Over Mars Rover Mission
Paris (AFP) Jan 17, 2007 Members of the European Space Agency face a looming tough decision over whether to cut back a planned unmanned mission to Mars or stump up extra cash, ESA Director General Jean-Jacques Dordain warned on Wednesday. The ExoMars mission entails sending a 200-kilo (440-pound) wheeled rover, which will carry a drill enabling it delve up to two metres (seven feet) below the surface to see if the Red Planet has microbial life, or the potential for it. ExoMars was initially planned for launch in 2011, but this date has already been postponed by two years to help resolve what its goals should be. In a New Year's meeting with the press here, Dordain said the rover was over-burdened with instruments compared with the launch capability of the Russian Soyuz rocket that has been contracted to take it aloft. ESA members will either have to lose some of the instruments so that the rover can be launched by a Soyuz, or opt for a bigger launcher, which will cost more money, he said. In 2005, ESA members earmarked 650 million euros (838 million dollars) for ExoMars. Dordain added there remained a question mark about how to get the precious data from the rover back to Earth. He said he was "not 100-percent sure" that a NASA orbiter swinging around Mars would be able to act as a relay, and this raised the question as to whether a European craft would be needed to play the linking role. "There's no point launching ExoMars if you then find that you don't have a communications link," Dordain pointed out. Turning to US President George W. Bush's scheme to revived manned missions to the Moon, Dordain said ESA had sketched four potential areas of contribution -- infrastructure that would be set up on the Moon, infrastructure that would be placed in orbit around it, a transport system and scientific experiments. "It won't be a question of deciding one area or another. It could be a combination, depending on the available budget," he said.
Source: Agence France-Presse Related Links European Space Agency Mars News and Information at MarsDaily.com Mars News and Information at MarsDaily.com Lunar Dreams and more
No Longevity Benefit With Growth Hormone
Washington DC (UPI) Jan 16, 2007Doctors said Monday their analysis of 31 scientific papers found that human growth hormone -- oft-touted as an anti-aging wonder -- does nothing to help a person live longer. However, the papers do show that use of the expensive therapy has the potential to create adverse side effects. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright Space.TV Corporation. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space.TV Corp on any Web page published or hosted by Space.TV Corp. Privacy Statement |
